• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSL:AU

75.6600 AUD 0.7600 1.01%

As of 01:10:10 ET on 10/24/2014.

Snapshot for CSL Ltd (CSL)

Open: 75.2500 Day's Range: 75.1400 - 75.8200 Volume: 1,074,520
Previous Close: 74.9000 52wk Range: 63.7700 - 75.8200 1-Yr Rtn: +15.79%

Stock Chart for CSL

No chart data available.
  • CSL:AU 75.6600
  • 1D
  • 1M
  • 1Y
74.9000
Interactive CSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSL

Current P/E Ratio (ttm) 24.6084
Estimated P/E(06/2015) 21.3880
Relative P/E vs. AS51 1.3266
Earnings Per Share (USD) (ttm) 2.7014
Est. EPS (USD) (06/2015) 3.1130
Est. PEG Ratio 1.6903
Market Cap (M AUD) 35,900.90
Shares Outstanding (M) 474.50
30 Day Average Volume 1,199,044
Price/Book (mrq) 9.9818
Price/Sale (ttm) 6.0282
Dividend Indicated Gross Yield 1.64%
Cash Dividend (AUD) 0.6485
Dividend Ex-Date 09/08/2014
5 Year Dividend Growth 12.07%
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSL

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
More Company Profile & Key Executives for CSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil